Advisor Net Financial, Inc Edwards Lifesciences Corp Transaction History

Advisor Net Financial, Inc

$1.13 Billion
Q4 2024

A detailed history of Advisor Net Financial, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 1,491 shares of EW stock, worth $106,427. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,491

Previous 1,832 18.61%

Holding current value

$106,427

Previous $120,000 8.33%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	SELL	$64.54 - $75.92 $22,008 - $25,888	-341 Reduced 18.61%	1,491 $110,000
Q3 2024 Oct 15, 2024	SELL	$59.7 - $93.78 $11,462 - $18,005	-192 Reduced 9.49%	1,832 $120,000
Q1 2024 Apr 12, 2024	SELL	$72.54 - $95.56 $6,818 - $8,982	-94 Reduced 4.44%	2,024 $193,000
Q4 2023 Jan 19, 2024	BUY	$61.71 - $77.76 $16,846 - $21,228	273 Added 14.8%	2,118 $161,000
Q3 2023 Oct 12, 2023	BUY	$69.28 - $93.38 $4,018 - $5,416	58 Added 3.25%	1,845 $127,000
Q2 2023 Jul 14, 2023	SELL	$81.41 - $94.33 $3,744 - $4,339	-46 Reduced 2.51%	1,787 $168,000
Q1 2023 Apr 28, 2023	BUY	$74.26 - $84.51 $13,960 - $15,887	188 Added 11.43%	1,833 $151,000
Q4 2022 Jan 13, 2023	BUY	$68.3 - $87.44 $3,483 - $4,459	51 Added 3.2%	1,645 $0
Q3 2022 Oct 04, 2022	SELL	$82.37 - $107.29 $14,826 - $19,312	-180 Reduced 10.15%	1,594 $132,000
Q2 2022 Jul 07, 2022	SELL	$86.5 - $128.27 $10,812 - $16,033	-125 Reduced 6.58%	1,774 $169,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $25,693 - $32,341	252 Added 15.3%	1,899 $224,000
Q4 2021 Jan 19, 2022	SELL	$106.37 - $130.68 $11,913 - $14,636	-112 Reduced 6.37%	1,647 $213,000
Q3 2021 Oct 15, 2021	BUY	$102.91 - $122.75 $79,755 - $95,131	775 Added 78.76%	1,759 $199,000
Q4 2020 Feb 04, 2021	SELL	$71.69 - $91.23 $4,158 - $5,291	-58 Reduced 5.57%	984 $90,000
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $5,778 - $7,519	-86 Reduced 7.62%	1,042 $83,000
Q2 2020 Aug 26, 2020	BUY	$57.54 - $76.95 $45,744 - $61,175	795 Added 238.74%	1,128 $78,000
Q3 2019 Oct 23, 2019	BUY	$61.55 - $75.43 $5,847 - $7,165	95 Added 39.92%	333 $73,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $548 - $696	-12 Reduced 4.8%	238 $41,000
Q2 2018 Jul 27, 2018	BUY	$42.45 - $51.3 $1,315 - $1,590	31 Added 14.16%	250 $36,000
Q4 2017 Feb 27, 2018	BUY	$33.79 - $39.39 $7,400 - $8,626	219	219 $25,000

Others Institutions Holding EW

# of Institutions

1,356

Shares Held

467M

Call Options Held

9.76M

Put Options Held

3.89M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Account

Advisor Net Financial, Inc Edwards Lifesciences Corp Transaction History